|
|
||||||||
Eur J Cardiothorac Surg 2004;25:964-970
© 2004 Elsevier Science NL
Department of Cardiothoracic and Vascular Surgery, Augustenburger Platz 1, Deutsches Herzzentrum Berlin, 13353 Berlin, Germany
Received 24 October 2003; received in revised form 26 February 2004; accepted 26 February 2004.
* Corresponding author. Tel.: +49-30-4593-2001; fax: +49-30-4593-2100
e-mail: hetzer{at}dhzb.de
Axial flow pumps have gained increased acceptance since their first clinical use in 1998. The present report summarizes the clinical experience with patients treated for severe cardiogenic shock for the first time with a newly developed axial flow pump with magnetically levitated bearings. Material and methods: The axial flow pump Incor was implanted in 24 patients between June 2002 and June 2003. All except one patient were men. In 16 patients dilative cardiomyopathy, in seven ischemic and in one restrictive cardiomypathy had been diagnosed. All patients presented with catecholamine-dependent end-stage heart failure, seven of them were on an artificial ventilator and three were dependent on intraaortic balloon pump support. All patients suffered from organ dysfunction resulting from low cardiac output. Results: There were no perioperative deaths. The 30-day mortality rate was 8% (n=2); 79% (n=19) of patients reached a condition to be discharged home. The cumulative time on the device is 6.9 years; the longest individual time up to July 1, 2003 is 12.6 months. There were no structural defects or failures of the system. In one case the controller had to be exchanged because of intermittent malfunction. Cardiac output ranged between 4 and 6 l in all instances and there were no cases of infection of the drive-line or the system. Hemolysis was present initially but was not detectable in the later course. There were three instances of transient ischemic attacks. Two patients developed late cardiac tamponade with re-opening of the chest after 9 and 14 days. In one patient persistent gastrointestinal bleeding required re-hospitalization and transfusion therapy. Two patients were weaned from the device after 6 and 7 months of support, respectively. Conclusion: The preliminary clinical experience with Incor is promising. The flow is sufficient for recovery from multiorgan failure and the pump allows long-term hemolysis-free support. The concept of magnetically levitated bearings has proven to be durable and reliable. In the case that the heart may recover through unloading, weaning from the pump is possible.
Key Words: Assist device Heart failure Magnetic levitation Incor Axial flow pump
This article has been cited by other articles:
![]() |
F. Nicolini and T. Gherli Alternatives to transplantation in the surgical therapy for heart failure Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 214 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Steinlechner, M. Dworschak, B. Birkenberg, M. Duris, P. Zeidler, H. Fischer, L. Milosevic, G. Wieselthaler, E. Wolner, P. Quehenberger, et al. Platelet Dysfunction in Outpatients With Left Ventricular Assist Devices Ann. Thorac. Surg., January 1, 2009; 87(1): 131 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Crow, R. John, A. Boyle, S. Shumway, K. Liao, M. Colvin-Adams, C. Toninato, E. Missov, M. Pritzker, C. Martin, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 208 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Komoda, Y. Weng, and R. Hetzer Technique for Insertion of the Inflow Cannula of the INCOR Left Ventricular Assist Device Ann. Thorac. Surg., April 1, 2008; 85(4): 1466 - 1467. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zierer, S. J. Melby, R. K. Voeller, T. J. Guthrie, G. A. Ewald, K. Shelton, M. K. Pasque, M. R. Moon, R. J. Damiano Jr, and N. Moazami Late-Onset Driveline Infections: The Achilles' Heel of Prolonged Left Ventricular Assist Device Support Ann. Thorac. Surg., August 1, 2007; 84(2): 515 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Haj-Yahia, E. J. Birks, P. Rogers, C. Bowles, M. Hipkins, R. George, M. Amrani, M. Petrou, J. Pepper, G. Dreyfus, et al. Midterm experience with the Jarvik 2000 axial flow left ventricular assist device J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 199 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tschirkov, D. Nikolov, G. Tinov, and V. Papantchev Successful implantation of Berlin Heart INCOR system after Bentall/De Bono operation Interactive CardioVascular and Thoracic Surgery, April 1, 2007; 6(2): 225 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Potapov, M. J. Jurmann, T. Drews, M. Pasic, M. Loebe, Y. Weng, and R. Hetzer Patients supported for over 4 years with left ventricular assist devices Eur J Heart Fail, November 1, 2006; 8(7): 756 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Wilhelm, C. Schmid, and H. H. Scheld Reply to the Editor: J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 210 - 211. [Full Text] [PDF] |
||||
![]() |
H. Habazettl, M. Kukucka, Y. G. Weng, W. M. Kuebler, R. Hetzer, H. Kuppe, and A. R. Pries Arteriolar Blood Flow Pulsatility in a Patient Before and After Implantation of an Axial Flow Pump Ann. Thorac. Surg., March 1, 2006; 81(3): 1109 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Potapov, Y. Weng, T. Drews, M. Jurmann, and R. Hetzer Longest Time of Support by the Novacor Left Ventricular Assist Device Without Pump Exchange Ann. Thorac. Surg., December 1, 2005; 80(6): 2421 - 2421. [Full Text] [PDF] |
||||
![]() |
D. J. Goldstein, M. Zucker, L. Arroyo, D. Baran, P. M. McCarthy, M. Loebe, and G. P. Noon Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation J. Am. Coll. Cardiol., March 15, 2005; 45(6): 962 - 963. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |